Cancer Registry Software Market- By Deployment , By Database Type , By Functionality , By Pricing Model , By End User , By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030.

Report Code: HCR 19954 Report Format: PDF + Excel

Cancer Registry Software Market Overview:

Cancer Registry Software Market size is estimated to reach $158 million by 2030, growing at a CAGR of 10.7% during the forecast period 2024-2030. Cancer registry software is a particular version of software application that is intended to manage data of cancer patients, their treatment, and results. It helps in maintaining the records of cancer cases baselines, Gander, and management of cases. This software aids the health care providers, including researchers and public health officials in evaluating the statistics, enhancing the quality of care to patients as well as carrying out studies of Epidemiology disease. The prevalence of cancer cases, the increase in research and development in the oncology sector, and government initiatives for cancer surveillance & need for improved cancer data management are set to drive the growth of the global Cancer Registry Software Market during the forecast period 2024-2030.  

Emerging trends in technology such as cloud computing and AI have improved the understanding of the registries and data analysis on patient information. The oncology field is experiencing a revolution in data administration and analysis with the introduction of Artificial Intelligence (AI) and Machine Learning (ML) into cancer registry software. AI systems can identify patterns and trends within populations and across treatment responses and cancer rates. This drives better outcomes and more selective action. In addition, the research and development activities coupled with the practice of tailored medicine avails vast amounts of data which, in turn, calls for sophisticated data management capabilities. This represents the Cancer Registry Software market outlook during the forecast period.

Market Snapshot: 


Cancer Registry Software Market- Report Coverage:

The “Cancer Registry Software Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Cancer Registry Software Market.

Attribute Segment

By Type
  • Stand-alone Software
  • Integrated Software

By Registry Type
  • Population-based Cancer Registry
  • Hospital-based Cancer Registry

By Deployment

By Database Type

By Functionality
  • Patient Care Management
  • Cancer Reporting
  • Medical Research
  • Clinical Studies
  • Treatment Outcome Evaluation

By Pricing Model
  • Subscription-based
  • Per User Licensing
  • One Time Purchase

By End User
  • Government Organizations
  • Third-Party Administrators
  • Biotechnological and Medical Device Companies
  • Research Centers

By Geography

  • North America (U.S, Canada and Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe),
  • Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific),
  • South America (Brazil, Argentina, Chile, Colombia and Rest of South America)
  • Rest of the World (Middle East and Africa).

Impact of Covid and Russia-Ukraine War:

  • The COVID-19 pandemic caused many disruptions in the patterns of cancer screening and treatment practice which resulted in the greater volume of information that needed to be gathered in order to track changes in cancer incidence and outcomes during the crisis. Several hospitals worldwide didn’t allow cancer diagnosis or treatments with cancer being considered a comorbid condition due to COVID. 
  • The ongoing Russia-Ukraine conflict had an indirect impact for the cancer registry software market. As governments allocate more resources to defense and military efforts, budget constraints limited investments in healthcare technologies, including cancer registry systems. This might hinder the development and implementation of advanced data management solutions necessary for tracking cancer incidence and outcomes. 

Key Takeaways:

  • Dominance of North America 

North America held the largest share of 37% in the Market in 2023 due to the incidence of cancer in the United States continues to be a leading cause of concern in public health, according to the American Cancer Society, with an estimated 611,000 cancer deaths anticipated in 2024 or about more than 1600 deaths daily. This net statistic is a call for heightened awareness and detection campaigns. For instance, a recent initiative in Texas sought to improve breast cancer screening rates by encouraging people to have check-ups regularly. As the number of cancer patients increases, there is a paradigm shift among healthcare providers, who are emphasizing newer treatment modalities, as well as complex data management systems.

On Cloud-based cancer registry software to Grow the Fastest

Cloud-based cancer registry software is holding the fastest share in the market due to its scalability, accessibility and cost-effectiveness. These tools facilitate provider cooperation in real time and help healthcare organisations manage massive amounts of patient data efficiently. For instance, in March 2024, Elekta and Merck & Co., Inc. collaborated to create a digital platform for patients with advanced renal cell cancer (RCC). This collaboration is an example of how cloud computing is propelling innovation in oncology by utilising digital solutions to improve kidney cancer care. Cloud-based solutions enable easy access to patient data from any location, enabling healthcare teams to make well-informed decisions that ultimately improve treatment outcomes and patient care in a quickly changing healthcare environment.

Public Database Cancer Registry Software holds the Largest Market share

Public database cancer registry software holds the largest segment share in the cancer registry market primarily due to its crucial role in public health initiatives and epidemiological research. These databases which are funded by government and health organizations are crucial for monitoring the incidence, death, and survival rates of cancer in various populations. They offer thorough data that guides the distribution of resources, public health policies, and cancer prevention tactics. As per Globocan 2022, close to 18 000 people are diagnosed with cancer each year in Guatemala, with numbers expected to substantially increase by 2045. In October 2024, the IAEA imPACT Review of Guatemala highlighted that strengthening cancer registries is a crucial step towards improving cancer prevention, diagnosis and treatment. Public registries also make it easier for researchers and medical professionals to work together, which improves our knowledge of cancer trends and treatment results in general. This data's accessibility is essential for developing cancer research and enhancing medical treatments. It is anticipated that public database cancer registry software will continue to gain popularity as population health becomes more of a priority.

Government Initiatives For Cancer Surveillance Drives The Cancer Registry Software Market 

Government initiatives for cancer surveillance are crucial in enhancing public health and improving early detection and management of cancer. To improve the general health and early cancer detection and management efforts, the government intervention regarding cancer monitoring is indispensable. In August 2024, the Ministry of Health and Family Welfare extended the National Programme for the Control of Diabetes, Cardiovascular Diseases and Stroke (NP-NCD) by adding new units and infrastructure that seeks to concentrate on early detection and treatment of various types of cancers. Also, under the Ayushman Bharat programme, the Government of India started promoting screening for non-communicable diseases (NCDs) and cancers at the population level. This aims to ensure that there is a screening pathway in place for the elders as currently over 1.4 million primary health care workers have been trained to increase screening for NCDs with a particular emphasis on prevention.

Data Privacy Concerns to Hamper Market Growth

The patient information is sensitive and addressing data privacy issues in cancer registry software are crucial. For instance, in July 2023, more than 11.27 million HCA healthcare patients affected by a cyberattack. Organizations must make sure that strong security measures are in place to guard against unauthorized access and data breaches especially in light of laws like HIPAA that require strict confidentiality. Furthermore, as cloud-based solutions proliferate, the difficulty of guaranteeing data security across several networks and platforms grows. Another issue is the sharing of data for research, which needs to be handled carefully to protect patient privacy

Cancer Registry Software Market Share by Geography, 2023 (%)   


Cancer Registry Software Market               

Key Market Players: 

The top 10 companies in the Cancer Registry Software Market are:

  1. Elekta
  2. Oracle Corporation
  3. Health Catalyst Inc
  4. McKesson Corporation
  5. C/NET Solutions
  6. Q-Centrix, LLC
  7. Conduent, Inc
  8. ONCO, Inc.
  9. NeuralFrame, Inc.
  10. Varian Medical Systems, Inc

Scope of Report: 

Report Metric Details

Base year considered

2023

Forecast period

2024–2030

CAGR

10.7%

Market Size in 2030

$158 million

Segments covered

By Type, By Registry Type, By Deployment, By Database Type, By Functionality, By Pricing Model, By End User, and By Geography

Geographies covered

North America (US, Canada and Mexico), Europe (Germany, France, UK, Italy, Netherlands, Spain, Belgium and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Companies covered
  1. Elekta
  2. Oracle Corporation
  3. Health Catalyst Inc
  4. McKesson Corporation
  5. C/NET Solutions
  6. Q-Centrix, LLC
  7. Conduent, Inc
  8. ONCO, Inc.
  9. NeuralFrame, Inc.
  10. Varian Medical Systems, Inc.

For more Lifesciences and Healthcare Market reports, please click here

  1. Cancer Registry Software Market - Market Overview
          1.1 Definitions and Scope
  2. Cancer Registry Software Market - Executive Summary
          2.1 Key trends by Type
          2.2 Key trends by Registry Type
          2.3 Key trends by Database Type
          2.4 Key Trends by Deployment
          2.4 Key trends by Functionality
          2.5 Key trends by Pricing Model
          2.6 Key trends by End User
          2.7 Key trends by Geography
  3. Cancer Registry Software Market – Landscape
          3.1 Comparative analysis
                    3.1.1 Market Share Analysis- Major Companies
                    3.1.2 Product Benchmarking- Major Companies
                    3.1.3 Major 5 Financials Analysis
                    3.1.4 Patent Analysis- Top Companies
                    3.1.5 Pricing Analysis (ASPs will be provided)
  4. Cancer Registry Software Market - Startup companies Scenario Premium 
          4.1 Top startup company Analysis by
                    4.1.1 Investment
                    4.1.2 Revenue
                    4.1.3 Market Shares
                    4.1.4 Market Size and Application Analysis
                    4.1.5 Venture Capital and Funding Scenario
  5. Cancer Registry Software Market – Industry Market Entry Scenario Premium 
          5.1 Regulatory Framework Overview
          5.2 New Business and Ease of Doing business index
          5.3 Successful venture profiles
          5.4 Customer Analysis – Major companies
  6. Cancer Registry Software Market - Market Forces
          6.1 Market Drivers
          6.2 Market Constraints
          6.3 Porters Five Force Model
                    6.3.1 Bargaining Power of Suppliers
                    6.3.2 Bargaining Powers of Buyers
                    6.3.3 Threat of New Entrants
                    6.3.4 Competitive Rivalry
                    6.3.5 Threat of Substitutes 
  7. Cancer Registry Software Market – Strategic Analysis
          7.1 Value/Supply Chain Analysis
          7.2 Opportunity Analysis
          7.3 Product/Market Life Cycle
          7.4 Distributor Analysis – Major Companies 
  8. Cancer Registry Software Market – By Type (Market Size -$Million/Billion)
          8.1 Standalone Software
          8.2 Integrated Software
  9. Cancer Registry Software Market – By Registry Type (Market Size -$Million/Billion)
         9.1 Population-based Cancer Registry
         9.2 Hospital-based Cancer Registry
  10. Cancer Registry Software Market – By Database Type (Market Size -$Million/Billion)
         10.1 Commercial Database
         10.2 Public Database
  11. Cancer Registry Software Market – By Deployment (Market Size -$Million/Billion)
          11.1 On-Premise
          11.2 On - Cloud
          11.3 Others
  12. Cancer Registry Software Market – By Functionality (Market Size -$Million/Billion)
          12.1 Patient Care Management
          12.2 Cancer Reporting
          12.3 Medical Research
          12.4 Clinical Studies
          12.5 Treatment Outcome Evaluation
          12.6 Others
   13. Cancer Registry Software Market – By Pricing Model (Market Size -$Million/Billion)
          13.1 Subscription-based
          13.2 Per User Licensing
          13.3 One-Time Purchase
    14. Cancer Registry Software Market – By End User (Market Size -$Million/Billion)
          14.1 Government Organizations
          14.2 Third-Party Administrators
          14.3 Biotechnological and Medical Device Companies
          14.4 Research Centers
          14.5 Hospitals 
          14.6 Private Payers
          14.7 Pharmaceutical Companies
          14.8 Non-Governmental Organizations (NGOs)
          14.5 Others
  15. Cancer Registry Software Market - By Geography (Market Size -$Million/Billion)
          15.1 North America
                    15.1.1 USA
                    15.1.2 Canada
                    15.1.3 Mexico
          15.2 Europe
                    15.2.1 UK
                    15.2.2 Germany
                    15.2.3 France
                    15.2.4 Italy
                    15.2.5 Netherlands
                    15.2.6 Spain
                    15.2.7 Belgium
                    15.2.8 Rest of Europe
          15.3 Asia-Pacific
                    15.3.1 China
                    15.3.2 Japan
                    15.3.3 India
                    15.3.4 South Korea
                    15.3.5 Indonesia
                    15.3.6 Australia
                    15.3.7 Malaysia
                    15.3.8 Thailand
                    15.3.9 Rest of APAC
          15.4 South America
                    15.4.1 Brazil
                    15.4.2 Argentina
                    15.4.3 Colombia
                    15.4.4 Chile
                    15.4.5 Rest of South America
          15.5 Rest of the World
                    15.5.1 Middle East
                    15.5.2 Africa
  16. Cancer Registry Software Market – Entropy
          16.1 New Product Launches
          16.2 M&As, Collaborations, JVs and Partnerships
  17. Cancer Registry Software Market – Market Share Analysis 
          17.1 Market Share at Global Level - Major companies
          17.2 Market Share by Key Region - Major companies
          17.3 Market Share by Key Country - Major companies
          17.4 Market Share by Key Application - Major companies
          17.5 Market Share by Key Product Type/Product category - Major companies
  18. Cancer Registry Software Market – Key Company List by Country Premium 
  19. Cancer Registry Software Market Company Analysis
          19.1 Elekta
          19.2 Oracle Corporation
          19.3 Health Catalyst Inc
         19.4 McKesson Corporation
         19.5 C/NET Solutions
         19.6 Q-Centrix, LLC
         19.7 Conduent, Inc
         19.8 Onco, Inc.
         19.9 NeuralFrame, Inc.
         19.10 Varian Medical Systems, Inc
  "*Financials would be provided on a best-effort basis for private companies*”
  Connect with our experts to get customized reports that best suit your requirements. Our 
  reports include global-level data, niche markets and competitive landscape.

LIST OF TABLES

1.Global Cancer Patient Registry Software Market, By Type Market 2023-2030 ($M)
1.1 Standalone Software Market 2023-2030 ($M) - Global Industry Research
1.1.1 Standalone Software Accounts for the Largest Share of the Market Market 2023-2030 ($M)
1.2 Integrated Software Market 2023-2030 ($M) - Global Industry Research
1.2.1 Advantages Such as Flexibility and Safety are Driving the Adoption of Integrated Software Market 2023-2030 ($M)
2.Global Cancer Patient Registry Software Market, By Deployment Model Market 2023-2030 ($M)
2.1 On-Premise Models Market 2023-2030 ($M) - Global Industry Research
2.1.1 On-Premise Models Segment Accounted for the Largest Share of the Market in Market 2023-2030 ($M)
2.2 Cloud-Based Models Market 2023-2030 ($M) - Global Industry Research
2.2.1 Cost-Effectiveness and Flexibility Have Ensured the Growth of Cloud-Based Models Market 2023-2030 ($M)
3.Global Cancer Patient Registry Software Market, By Database Type Market 2023-2030 ($M)
3.1 Commercial Databases Market 2023-2030 ($M) - Global Industry Research
3.1.1 Commercial Databases Segment Hold the Largest Share in the Cancer Patient Registry Software Market Market 2023-2030 ($M)
3.2 Public Databases Market 2023-2030 ($M) - Global Industry Research
3.2.1 Public Databases are Used for Data Collection for A Specific Research Agenda Market 2023-2030 ($M)
4.Global Cancer Patient Registry Software Market, By Functionality Market 2023-2030 ($M)
4.1 Cancer Reporting to Meet State and Federal Regulations Market 2023-2030 ($M) - Global Industry Research
4.1.1 Stringent and Rapidly Changing State and Federal Regulations for Cancer Reporting to Drive the Growth of This Segment Market 2023-2030 ($M)
4.2 Patient Care Management Market 2023-2030 ($M) - Global Industry Research
4.2.1 Market Players are Expected to Focus on Developing Solutions Designed With Automated Patient Outreach Facility for Optimum Patient Care Management Market 2023-2030 ($M)
4.3 Medical Research & Clinical Studies Market 2023-2030 ($M) - Global Industry Research
4.3.1 Several Research Organizations are Expected to Support and Encourage the Creation of Registries for Clinical Research Market 2023-2030 ($M)
4.4 Product Outcome Evaluation Market 2023-2030 ($M) - Global Industry Research
4.4.1 Product Outcome Evaluation Functionality has Major Applications in Post-Marketing Surveillance in the Pharmaceutical Industry Market 2023-2030 ($M)
5.Global Cancer Patient Registry Software Market, By End User Market 2023-2030 ($M)
5.1 Government Organizations & Third-Party Administrators Market 2023-2030 ($M) - Global Industry Research
5.1.1 Growing Government Initiatives to Drive the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
5.2 Hospitals & Medical Practices Market 2023-2030 ($M) - Global Industry Research
5.3 Private Payers Market 2023-2030 ($M) - Global Industry Research
5.3.1 Role of Cancer Patient Registry Software in the Effective Determination of Healthcare Coverage Policies to Drive Its Demand Among Payers Market 2023-2030 ($M)
5.4 Pharmaceutical, Biotechnology, and Medical Device Companies Market 2023-2030 ($M) - Global Industry Research
5.4.1 Increased Need for Post-Marketing Surveillance Driving the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
5.5 Research Centers Market 2023-2030 ($M) - Global Industry Research
5.5.1 Cancer Patient Registry Software Makes It Easier for Research Centers to Gather Relevant Information on Cancer Patients Market 2023-2030 ($M)
6.Global Cancer Patient Registry Software Market, By Type Market 2023-2030 (Volume/Units)
6.1 Standalone Software Market 2023-2030 (Volume/Units) - Global Industry Research
6.1.1 Standalone Software Accounts for the Largest Share of the Market Market 2023-2030 (Volume/Units)
6.2 Integrated Software Market 2023-2030 (Volume/Units) - Global Industry Research
6.2.1 Advantages Such as Flexibility and Safety are Driving the Adoption of Integrated Software Market 2023-2030 (Volume/Units)
7.Global Cancer Patient Registry Software Market, By Deployment Model Market 2023-2030 (Volume/Units)
7.1 On-Premise Models Market 2023-2030 (Volume/Units) - Global Industry Research
7.1.1 On-Premise Models Segment Accounted for the Largest Share of the Market in Market 2023-2030 (Volume/Units)
7.2 Cloud-Based Models Market 2023-2030 (Volume/Units) - Global Industry Research
7.2.1 Cost-Effectiveness and Flexibility Have Ensured the Growth of Cloud-Based Models Market 2023-2030 (Volume/Units)
8.Global Cancer Patient Registry Software Market, By Database Type Market 2023-2030 (Volume/Units)
8.1 Commercial Databases Market 2023-2030 (Volume/Units) - Global Industry Research
8.1.1 Commercial Databases Segment Hold the Largest Share in the Cancer Patient Registry Software Market Market 2023-2030 (Volume/Units)
8.2 Public Databases Market 2023-2030 (Volume/Units) - Global Industry Research
8.2.1 Public Databases are Used for Data Collection for A Specific Research Agenda Market 2023-2030 (Volume/Units)
9.Global Cancer Patient Registry Software Market, By Functionality Market 2023-2030 (Volume/Units)
9.1 Cancer Reporting to Meet State and Federal Regulations Market 2023-2030 (Volume/Units) - Global Industry Research
9.1.1 Stringent and Rapidly Changing State and Federal Regulations for Cancer Reporting to Drive the Growth of This Segment Market 2023-2030 (Volume/Units)
9.2 Patient Care Management Market 2023-2030 (Volume/Units) - Global Industry Research
9.2.1 Market Players are Expected to Focus on Developing Solutions Designed With Automated Patient Outreach Facility for Optimum Patient Care Management Market 2023-2030 (Volume/Units)
9.3 Medical Research & Clinical Studies Market 2023-2030 (Volume/Units) - Global Industry Research
9.3.1 Several Research Organizations are Expected to Support and Encourage the Creation of Registries for Clinical Research Market 2023-2030 (Volume/Units)
9.4 Product Outcome Evaluation Market 2023-2030 (Volume/Units) - Global Industry Research
9.4.1 Product Outcome Evaluation Functionality has Major Applications in Post-Marketing Surveillance in the Pharmaceutical Industry Market 2023-2030 (Volume/Units)
10.Global Cancer Patient Registry Software Market, By End User Market 2023-2030 (Volume/Units)
10.1 Government Organizations & Third-Party Administrators Market 2023-2030 (Volume/Units) - Global Industry Research
10.1.1 Growing Government Initiatives to Drive the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 (Volume/Units)
10.2 Hospitals & Medical Practices Market 2023-2030 (Volume/Units) - Global Industry Research
10.3 Private Payers Market 2023-2030 (Volume/Units) - Global Industry Research
10.3.1 Role of Cancer Patient Registry Software in the Effective Determination of Healthcare Coverage Policies to Drive Its Demand Among Payers Market 2023-2030 (Volume/Units)
10.4 Pharmaceutical, Biotechnology, and Medical Device Companies Market 2023-2030 (Volume/Units) - Global Industry Research
10.4.1 Increased Need for Post-Marketing Surveillance Driving the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 (Volume/Units)
10.5 Research Centers Market 2023-2030 (Volume/Units) - Global Industry Research
10.5.1 Cancer Patient Registry Software Makes It Easier for Research Centers to Gather Relevant Information on Cancer Patients Market 2023-2030 (Volume/Units)
11.North America Cancer Patient Registry Software Market, By Type Market 2023-2030 ($M)
11.1 Standalone Software Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Standalone Software Accounts for the Largest Share of the Market Market 2023-2030 ($M)
11.2 Integrated Software Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Advantages Such as Flexibility and Safety are Driving the Adoption of Integrated Software Market 2023-2030 ($M)
12.North America Cancer Patient Registry Software Market, By Deployment Model Market 2023-2030 ($M)
12.1 On-Premise Models Market 2023-2030 ($M) - Regional Industry Research
12.1.1 On-Premise Models Segment Accounted for the Largest Share of the Market in Market 2023-2030 ($M)
12.2 Cloud-Based Models Market 2023-2030 ($M) - Regional Industry Research
12.2.1 Cost-Effectiveness and Flexibility Have Ensured the Growth of Cloud-Based Models Market 2023-2030 ($M)
13.North America Cancer Patient Registry Software Market, By Database Type Market 2023-2030 ($M)
13.1 Commercial Databases Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Commercial Databases Segment Hold the Largest Share in the Cancer Patient Registry Software Market Market 2023-2030 ($M)
13.2 Public Databases Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Public Databases are Used for Data Collection for A Specific Research Agenda Market 2023-2030 ($M)
14.North America Cancer Patient Registry Software Market, By Functionality Market 2023-2030 ($M)
14.1 Cancer Reporting to Meet State and Federal Regulations Market 2023-2030 ($M) - Regional Industry Research
14.1.1 Stringent and Rapidly Changing State and Federal Regulations for Cancer Reporting to Drive the Growth of This Segment Market 2023-2030 ($M)
14.2 Patient Care Management Market 2023-2030 ($M) - Regional Industry Research
14.2.1 Market Players are Expected to Focus on Developing Solutions Designed With Automated Patient Outreach Facility for Optimum Patient Care Management Market 2023-2030 ($M)
14.3 Medical Research & Clinical Studies Market 2023-2030 ($M) - Regional Industry Research
14.3.1 Several Research Organizations are Expected to Support and Encourage the Creation of Registries for Clinical Research Market 2023-2030 ($M)
14.4 Product Outcome Evaluation Market 2023-2030 ($M) - Regional Industry Research
14.4.1 Product Outcome Evaluation Functionality has Major Applications in Post-Marketing Surveillance in the Pharmaceutical Industry Market 2023-2030 ($M)
15.North America Cancer Patient Registry Software Market, By End User Market 2023-2030 ($M)
15.1 Government Organizations & Third-Party Administrators Market 2023-2030 ($M) - Regional Industry Research
15.1.1 Growing Government Initiatives to Drive the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
15.2 Hospitals & Medical Practices Market 2023-2030 ($M) - Regional Industry Research
15.3 Private Payers Market 2023-2030 ($M) - Regional Industry Research
15.3.1 Role of Cancer Patient Registry Software in the Effective Determination of Healthcare Coverage Policies to Drive Its Demand Among Payers Market 2023-2030 ($M)
15.4 Pharmaceutical, Biotechnology, and Medical Device Companies Market 2023-2030 ($M) - Regional Industry Research
15.4.1 Increased Need for Post-Marketing Surveillance Driving the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
15.5 Research Centers Market 2023-2030 ($M) - Regional Industry Research
15.5.1 Cancer Patient Registry Software Makes It Easier for Research Centers to Gather Relevant Information on Cancer Patients Market 2023-2030 ($M)
16.South America Cancer Patient Registry Software Market, By Type Market 2023-2030 ($M)
16.1 Standalone Software Market 2023-2030 ($M) - Regional Industry Research
16.1.1 Standalone Software Accounts for the Largest Share of the Market Market 2023-2030 ($M)
16.2 Integrated Software Market 2023-2030 ($M) - Regional Industry Research
16.2.1 Advantages Such as Flexibility and Safety are Driving the Adoption of Integrated Software Market 2023-2030 ($M)
17.South America Cancer Patient Registry Software Market, By Deployment Model Market 2023-2030 ($M)
17.1 On-Premise Models Market 2023-2030 ($M) - Regional Industry Research
17.1.1 On-Premise Models Segment Accounted for the Largest Share of the Market in Market 2023-2030 ($M)
17.2 Cloud-Based Models Market 2023-2030 ($M) - Regional Industry Research
17.2.1 Cost-Effectiveness and Flexibility Have Ensured the Growth of Cloud-Based Models Market 2023-2030 ($M)
18.South America Cancer Patient Registry Software Market, By Database Type Market 2023-2030 ($M)
18.1 Commercial Databases Market 2023-2030 ($M) - Regional Industry Research
18.1.1 Commercial Databases Segment Hold the Largest Share in the Cancer Patient Registry Software Market Market 2023-2030 ($M)
18.2 Public Databases Market 2023-2030 ($M) - Regional Industry Research
18.2.1 Public Databases are Used for Data Collection for A Specific Research Agenda Market 2023-2030 ($M)
19.South America Cancer Patient Registry Software Market, By Functionality Market 2023-2030 ($M)
19.1 Cancer Reporting to Meet State and Federal Regulations Market 2023-2030 ($M) - Regional Industry Research
19.1.1 Stringent and Rapidly Changing State and Federal Regulations for Cancer Reporting to Drive the Growth of This Segment Market 2023-2030 ($M)
19.2 Patient Care Management Market 2023-2030 ($M) - Regional Industry Research
19.2.1 Market Players are Expected to Focus on Developing Solutions Designed With Automated Patient Outreach Facility for Optimum Patient Care Management Market 2023-2030 ($M)
19.3 Medical Research & Clinical Studies Market 2023-2030 ($M) - Regional Industry Research
19.3.1 Several Research Organizations are Expected to Support and Encourage the Creation of Registries for Clinical Research Market 2023-2030 ($M)
19.4 Product Outcome Evaluation Market 2023-2030 ($M) - Regional Industry Research
19.4.1 Product Outcome Evaluation Functionality has Major Applications in Post-Marketing Surveillance in the Pharmaceutical Industry Market 2023-2030 ($M)
20.South America Cancer Patient Registry Software Market, By End User Market 2023-2030 ($M)
20.1 Government Organizations & Third-Party Administrators Market 2023-2030 ($M) - Regional Industry Research
20.1.1 Growing Government Initiatives to Drive the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
20.2 Hospitals & Medical Practices Market 2023-2030 ($M) - Regional Industry Research
20.3 Private Payers Market 2023-2030 ($M) - Regional Industry Research
20.3.1 Role of Cancer Patient Registry Software in the Effective Determination of Healthcare Coverage Policies to Drive Its Demand Among Payers Market 2023-2030 ($M)
20.4 Pharmaceutical, Biotechnology, and Medical Device Companies Market 2023-2030 ($M) - Regional Industry Research
20.4.1 Increased Need for Post-Marketing Surveillance Driving the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
20.5 Research Centers Market 2023-2030 ($M) - Regional Industry Research
20.5.1 Cancer Patient Registry Software Makes It Easier for Research Centers to Gather Relevant Information on Cancer Patients Market 2023-2030 ($M)
21.Europe Cancer Patient Registry Software Market, By Type Market 2023-2030 ($M)
21.1 Standalone Software Market 2023-2030 ($M) - Regional Industry Research
21.1.1 Standalone Software Accounts for the Largest Share of the Market Market 2023-2030 ($M)
21.2 Integrated Software Market 2023-2030 ($M) - Regional Industry Research
21.2.1 Advantages Such as Flexibility and Safety are Driving the Adoption of Integrated Software Market 2023-2030 ($M)
22.Europe Cancer Patient Registry Software Market, By Deployment Model Market 2023-2030 ($M)
22.1 On-Premise Models Market 2023-2030 ($M) - Regional Industry Research
22.1.1 On-Premise Models Segment Accounted for the Largest Share of the Market in Market 2023-2030 ($M)
22.2 Cloud-Based Models Market 2023-2030 ($M) - Regional Industry Research
22.2.1 Cost-Effectiveness and Flexibility Have Ensured the Growth of Cloud-Based Models Market 2023-2030 ($M)
23.Europe Cancer Patient Registry Software Market, By Database Type Market 2023-2030 ($M)
23.1 Commercial Databases Market 2023-2030 ($M) - Regional Industry Research
23.1.1 Commercial Databases Segment Hold the Largest Share in the Cancer Patient Registry Software Market Market 2023-2030 ($M)
23.2 Public Databases Market 2023-2030 ($M) - Regional Industry Research
23.2.1 Public Databases are Used for Data Collection for A Specific Research Agenda Market 2023-2030 ($M)
24.Europe Cancer Patient Registry Software Market, By Functionality Market 2023-2030 ($M)
24.1 Cancer Reporting to Meet State and Federal Regulations Market 2023-2030 ($M) - Regional Industry Research
24.1.1 Stringent and Rapidly Changing State and Federal Regulations for Cancer Reporting to Drive the Growth of This Segment Market 2023-2030 ($M)
24.2 Patient Care Management Market 2023-2030 ($M) - Regional Industry Research
24.2.1 Market Players are Expected to Focus on Developing Solutions Designed With Automated Patient Outreach Facility for Optimum Patient Care Management Market 2023-2030 ($M)
24.3 Medical Research & Clinical Studies Market 2023-2030 ($M) - Regional Industry Research
24.3.1 Several Research Organizations are Expected to Support and Encourage the Creation of Registries for Clinical Research Market 2023-2030 ($M)
24.4 Product Outcome Evaluation Market 2023-2030 ($M) - Regional Industry Research
24.4.1 Product Outcome Evaluation Functionality has Major Applications in Post-Marketing Surveillance in the Pharmaceutical Industry Market 2023-2030 ($M)
25.Europe Cancer Patient Registry Software Market, By End User Market 2023-2030 ($M)
25.1 Government Organizations & Third-Party Administrators Market 2023-2030 ($M) - Regional Industry Research
25.1.1 Growing Government Initiatives to Drive the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
25.2 Hospitals & Medical Practices Market 2023-2030 ($M) - Regional Industry Research
25.3 Private Payers Market 2023-2030 ($M) - Regional Industry Research
25.3.1 Role of Cancer Patient Registry Software in the Effective Determination of Healthcare Coverage Policies to Drive Its Demand Among Payers Market 2023-2030 ($M)
25.4 Pharmaceutical, Biotechnology, and Medical Device Companies Market 2023-2030 ($M) - Regional Industry Research
25.4.1 Increased Need for Post-Marketing Surveillance Driving the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
25.5 Research Centers Market 2023-2030 ($M) - Regional Industry Research
25.5.1 Cancer Patient Registry Software Makes It Easier for Research Centers to Gather Relevant Information on Cancer Patients Market 2023-2030 ($M)
26.APAC Cancer Patient Registry Software Market, By Type Market 2023-2030 ($M)
26.1 Standalone Software Market 2023-2030 ($M) - Regional Industry Research
26.1.1 Standalone Software Accounts for the Largest Share of the Market Market 2023-2030 ($M)
26.2 Integrated Software Market 2023-2030 ($M) - Regional Industry Research
26.2.1 Advantages Such as Flexibility and Safety are Driving the Adoption of Integrated Software Market 2023-2030 ($M)
27.APAC Cancer Patient Registry Software Market, By Deployment Model Market 2023-2030 ($M)
27.1 On-Premise Models Market 2023-2030 ($M) - Regional Industry Research
27.1.1 On-Premise Models Segment Accounted for the Largest Share of the Market in Market 2023-2030 ($M)
27.2 Cloud-Based Models Market 2023-2030 ($M) - Regional Industry Research
27.2.1 Cost-Effectiveness and Flexibility Have Ensured the Growth of Cloud-Based Models Market 2023-2030 ($M)
28.APAC Cancer Patient Registry Software Market, By Database Type Market 2023-2030 ($M)
28.1 Commercial Databases Market 2023-2030 ($M) - Regional Industry Research
28.1.1 Commercial Databases Segment Hold the Largest Share in the Cancer Patient Registry Software Market Market 2023-2030 ($M)
28.2 Public Databases Market 2023-2030 ($M) - Regional Industry Research
28.2.1 Public Databases are Used for Data Collection for A Specific Research Agenda Market 2023-2030 ($M)
29.APAC Cancer Patient Registry Software Market, By Functionality Market 2023-2030 ($M)
29.1 Cancer Reporting to Meet State and Federal Regulations Market 2023-2030 ($M) - Regional Industry Research
29.1.1 Stringent and Rapidly Changing State and Federal Regulations for Cancer Reporting to Drive the Growth of This Segment Market 2023-2030 ($M)
29.2 Patient Care Management Market 2023-2030 ($M) - Regional Industry Research
29.2.1 Market Players are Expected to Focus on Developing Solutions Designed With Automated Patient Outreach Facility for Optimum Patient Care Management Market 2023-2030 ($M)
29.3 Medical Research & Clinical Studies Market 2023-2030 ($M) - Regional Industry Research
29.3.1 Several Research Organizations are Expected to Support and Encourage the Creation of Registries for Clinical Research Market 2023-2030 ($M)
29.4 Product Outcome Evaluation Market 2023-2030 ($M) - Regional Industry Research
29.4.1 Product Outcome Evaluation Functionality has Major Applications in Post-Marketing Surveillance in the Pharmaceutical Industry Market 2023-2030 ($M)
30.APAC Cancer Patient Registry Software Market, By End User Market 2023-2030 ($M)
30.1 Government Organizations & Third-Party Administrators Market 2023-2030 ($M) - Regional Industry Research
30.1.1 Growing Government Initiatives to Drive the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
30.2 Hospitals & Medical Practices Market 2023-2030 ($M) - Regional Industry Research
30.3 Private Payers Market 2023-2030 ($M) - Regional Industry Research
30.3.1 Role of Cancer Patient Registry Software in the Effective Determination of Healthcare Coverage Policies to Drive Its Demand Among Payers Market 2023-2030 ($M)
30.4 Pharmaceutical, Biotechnology, and Medical Device Companies Market 2023-2030 ($M) - Regional Industry Research
30.4.1 Increased Need for Post-Marketing Surveillance Driving the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
30.5 Research Centers Market 2023-2030 ($M) - Regional Industry Research
30.5.1 Cancer Patient Registry Software Makes It Easier for Research Centers to Gather Relevant Information on Cancer Patients Market 2023-2030 ($M)
31.MENA Cancer Patient Registry Software Market, By Type Market 2023-2030 ($M)
31.1 Standalone Software Market 2023-2030 ($M) - Regional Industry Research
31.1.1 Standalone Software Accounts for the Largest Share of the Market Market 2023-2030 ($M)
31.2 Integrated Software Market 2023-2030 ($M) - Regional Industry Research
31.2.1 Advantages Such as Flexibility and Safety are Driving the Adoption of Integrated Software Market 2023-2030 ($M)
32.MENA Cancer Patient Registry Software Market, By Deployment Model Market 2023-2030 ($M)
32.1 On-Premise Models Market 2023-2030 ($M) - Regional Industry Research
32.1.1 On-Premise Models Segment Accounted for the Largest Share of the Market in Market 2023-2030 ($M)
32.2 Cloud-Based Models Market 2023-2030 ($M) - Regional Industry Research
32.2.1 Cost-Effectiveness and Flexibility Have Ensured the Growth of Cloud-Based Models Market 2023-2030 ($M)
33.MENA Cancer Patient Registry Software Market, By Database Type Market 2023-2030 ($M)
33.1 Commercial Databases Market 2023-2030 ($M) - Regional Industry Research
33.1.1 Commercial Databases Segment Hold the Largest Share in the Cancer Patient Registry Software Market Market 2023-2030 ($M)
33.2 Public Databases Market 2023-2030 ($M) - Regional Industry Research
33.2.1 Public Databases are Used for Data Collection for A Specific Research Agenda Market 2023-2030 ($M)
34.MENA Cancer Patient Registry Software Market, By Functionality Market 2023-2030 ($M)
34.1 Cancer Reporting to Meet State and Federal Regulations Market 2023-2030 ($M) - Regional Industry Research
34.1.1 Stringent and Rapidly Changing State and Federal Regulations for Cancer Reporting to Drive the Growth of This Segment Market 2023-2030 ($M)
34.2 Patient Care Management Market 2023-2030 ($M) - Regional Industry Research
34.2.1 Market Players are Expected to Focus on Developing Solutions Designed With Automated Patient Outreach Facility for Optimum Patient Care Management Market 2023-2030 ($M)
34.3 Medical Research & Clinical Studies Market 2023-2030 ($M) - Regional Industry Research
34.3.1 Several Research Organizations are Expected to Support and Encourage the Creation of Registries for Clinical Research Market 2023-2030 ($M)
34.4 Product Outcome Evaluation Market 2023-2030 ($M) - Regional Industry Research
34.4.1 Product Outcome Evaluation Functionality has Major Applications in Post-Marketing Surveillance in the Pharmaceutical Industry Market 2023-2030 ($M)
35.MENA Cancer Patient Registry Software Market, By End User Market 2023-2030 ($M)
35.1 Government Organizations & Third-Party Administrators Market 2023-2030 ($M) - Regional Industry Research
35.1.1 Growing Government Initiatives to Drive the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
35.2 Hospitals & Medical Practices Market 2023-2030 ($M) - Regional Industry Research
35.3 Private Payers Market 2023-2030 ($M) - Regional Industry Research
35.3.1 Role of Cancer Patient Registry Software in the Effective Determination of Healthcare Coverage Policies to Drive Its Demand Among Payers Market 2023-2030 ($M)
35.4 Pharmaceutical, Biotechnology, and Medical Device Companies Market 2023-2030 ($M) - Regional Industry Research
35.4.1 Increased Need for Post-Marketing Surveillance Driving the Demand for Cancer Patient Registry Software in This End-User Segment Market 2023-2030 ($M)
35.5 Research Centers Market 2023-2030 ($M) - Regional Industry Research
35.5.1 Cancer Patient Registry Software Makes It Easier for Research Centers to Gather Relevant Information on Cancer Patients Market 2023-2030 ($M)

LIST OF FIGURES

1.US Cancer Registry Software Market Revenue, 2023-2030 ($M)
2.Canada Cancer Registry Software Market Revenue, 2023-2030 ($M)
3.Mexico Cancer Registry Software Market Revenue, 2023-2030 ($M)
4.Brazil Cancer Registry Software Market Revenue, 2023-2030 ($M)
5.Argentina Cancer Registry Software Market Revenue, 2023-2030 ($M)
6.Peru Cancer Registry Software Market Revenue, 2023-2030 ($M)
7.Colombia Cancer Registry Software Market Revenue, 2023-2030 ($M)
8.Chile Cancer Registry Software Market Revenue, 2023-2030 ($M)
9.Rest of South America Cancer Registry Software Market Revenue, 2023-2030 ($M)
10.UK Cancer Registry Software Market Revenue, 2023-2030 ($M)
11.Germany Cancer Registry Software Market Revenue, 2023-2030 ($M)
12.France Cancer Registry Software Market Revenue, 2023-2030 ($M)
13.Italy Cancer Registry Software Market Revenue, 2023-2030 ($M)
14.Spain Cancer Registry Software Market Revenue, 2023-2030 ($M)
15.Rest of Europe Cancer Registry Software Market Revenue, 2023-2030 ($M)
16.China Cancer Registry Software Market Revenue, 2023-2030 ($M)
17.India Cancer Registry Software Market Revenue, 2023-2030 ($M)
18.Japan Cancer Registry Software Market Revenue, 2023-2030 ($M)
19.South Korea Cancer Registry Software Market Revenue, 2023-2030 ($M)
20.South Africa Cancer Registry Software Market Revenue, 2023-2030 ($M)
21.North America Cancer Registry Software By Application
22.South America Cancer Registry Software By Application
23.Europe Cancer Registry Software By Application
24.APAC Cancer Registry Software By Application
25.MENA Cancer Registry Software By Application
26.Onco, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.C/Net Solutions, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Elekta AB, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Rocky Mountain Cancer Data Systems, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Electronic Registry Systems, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Mckesson Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)

The Cancer Registry Software Market is forecast to grow at 10.7% during the forecast period 2024 -2030

Global Cancer Registry Software Market size is estimated to be US$77.3 million in 2023 and is projected to reach US$158 million by 2030.

Elekta, Oracle Corporation, Health Catalyst Inc., McKesson Corporation, C/NET Solutions & Others.

Integration of AI & ML and the shift toward cloud-based cancer registry platforms are some of the trends in the Cancer Registry Software Market.

The prevalence of cancer cases, the increase in research and development in the oncology sector, genomic data integration and use of big data analytics are set to drive the growth of the global Cancer Registry Software Market during the forecast period 2024-2030.